Web page content
Controlling respiratory disease in pigs is a difficult task. The numerous pathogens, interactions
between the pathogens and different variables on individual farms make it a complicated syndrome.
Identification of the main pathogens involved on an individual farm and the selection of the
appropriate vaccination program for that farm is vital for good production results. Intervet/Schering-Plough Animal Health
provides vets with a technical partnership in the ever changing battle against Porcine Respiratory Disease
Complex (PRDC). Skilled staff, diagnostic expertise and a full range of respiratory vaccines are available.
Through the partnership of Intervet/Schering-Plough Animal Health and the pig veterinarian, pig producers can improve productivity and profits.
Vaccines to help control PRDC
- Porcilis PRRS: A PRRSV live vaccine based on an EU strain to protect
against the economic losses of a PRRSV infection
- Porcilis M Hyo: An effective vaccine against M. hyopneumoniae
with no interference by MDA
- M+PAC: an oil-and-water adjuvanted vaccine for control of M. hyopneumoniae in pigs
- Porcilis APP: An A. pleuropneumoniae subunit vaccine containing
APXI, APXII, APXIII and OMP antigens offering broad protection
- Porcilis Glässer: The H. parasuis vaccine with proven
efficacy against the most important serotypes
- Porcilis Begonia: An ultimate weapon in the control of
Aujeszky’s Disease Virus
- Porcilis AR-T: A highly effective vaccine containing
P. multocida non-toxic toxoid and B. bronchiseptica antigens.
- Porcilis PCV: An inactivated vaccine against Porcine circovirus infection developed and produced in Boxmeer, the Netherlands.
- Circumvent PCV: An inactivated vaccine against Porcine circovirus infection developed and produced in Desoto in the USA.
Diluvac Forte, a unique adjuvant
Diluvac Forte, a unique, patented dl-α-tocopherol (vitamin E) based formulation was specially developed
for the Intervet/Schering-Plough Animal Health pig range to:
- Increase stimulation of T- and B-lymphocytes.
- Increase phagocytosis.
- Protect immune cells from critical damage by peroxidases.
By incorporating vitamin E into the adjuvant, these effects at the vaccination site result in
a prolonged and enhanced immune response. Diluvac Forte is also very tissue tolerant, causing no
reaction at the injection site.
[image not included in email]
Histology of muscle tissue 14 days after mineral oil adjuvant application
[image not included in email]
Histology of muscle tissue 14 days after Diluvac Forte application
The aqueous formulation means:
- Low viscosity and excellent syringeability, even at low temperatures.
- No foaming.
- Vaccination equipment is easy to clean
Diluvac Forte is thus the standard choice of adjuvant for Intervet/Schering-Plough Animal Health’s pig vaccine range.
Contact form
Ask the expert
Print
Print text
Bookmark
Color
b & w
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none)%3B){kind=small}
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none)%3B){kind=small}